Heyholder
‹ Activism Filings

Aimed Bio Inc. Q3 operating loss of KRW 6.7 billion, cumulative revenue of KRW 30.0 billion

Aimed Bio Inc.· Periodic Report

AI summary · Not investment advice

Aimed Bio sold KRW 1.3 billion in Q3 and lost KRW 6.7 billion from its main business, turning to a loss from the previous quarter.

Operating profit · 3 months

KRW -6.7 billion

Key facts

Revenue (3 months)
KRW 1.3 billion
Net income (3 months)
KRW -9.5 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 114.2 million
Revenue (year to date)
KRW 30.0 billion
Operating profit (prior-year 3 months)
KRW -5.9 billion
Operating profit (year to date)
KRW -2.1 billion
Net income (prior-year 3 months)
KRW -5.2 billion
Net income (year to date)
KRW -661.2 million

Commentary

AI commentary · Not investment advice

What happened

Aimed Bio filed its quarterly report with consolidated results for the third quarter of 2026. Sales for the latest 3 months were KRW 1.27 billion. That is up 1014.8% from the same 3 months a year earlier (KRW 114.2 million). It is down 93.7% from the previous quarter.

In the company's terms

Operating profit (money earned from the core business) was a loss of KRW 6.71 billion for the 3 months. A year earlier, the loss was KRW 5.87 billion. The previous quarter was not a loss, so this is a swing back into loss.

What changes for shareholders

Net income (the final profit after all costs and taxes) was a loss of KRW 9.53 billion for the 3 months. A year earlier, the loss was KRW 5.20 billion. This also swung into loss from the previous quarter.

For the year to date (Jan 1 to Sep 30), sales were KRW 29.97 billion. Operating profit was a loss of KRW 2.14 billion. Net income was a loss of KRW 661.2 million.

Comments

No comments yet

Comments from shareholders will appear here.